Trinity Biotech Invt Ltd.
13F holders, Q1 2024 (March 31)19holders
1famous investor
$2.04avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding Trinity Biotech Invt Ltd. in their 13F filings. The largest holders were Perceptive Advisors LLC ($3.7M), Hunter Associates Investment Management LLC ($644K) and Renaissance Technologies ($545K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Trinity Biotech Invt Ltd.
- CUSIP
- 896438504
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $3.8M |
| Exits | 0 | $0 |
Ownership 19 holders
| Perceptive Advisors LLC | 0.06% | New | 1,800,000 | $3.7M |
| Hunter Associates Investment Management LLC | 0.11% | Reduce -2.3% | 317,810 | $644K |
| Renaissance Technologies | 0.00% | Reduce -1.3% | 267,353 | $545K |
| Stonehill Capital Management LLC | 1.15% | Reduce -17.9% | 248,399 | $507K |
| Acadian Asset Management LLC | 0.00% | Reduce -15.1% | 116,276 | $237K |
| Whitefort Capital Management, LP | 0.11% | No change | 81,902 | $167K |
| Moss Adams Wealth Advisors LLC | 0.01% | New | 25,666 | $52K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 22,280 | $45K |
| Becker Capital Management Inc. | 0.00% | No change | 18,000 | $37K |
| Susquehanna International Group, LLP | 0.00% | New | 13,572 | $28K |
| UBS Group AG | 0.00% | Add +152194.1% | 5,178 | $11K |
| Morgan Stanley | 0.00% | No change | 2,910 | $6K |
| Global Retirement Partners, LLC | 0.00% | New | 800 | $2K |
| Rhumbline Advisers | 0.00% | No change | 372 | $761 |
| CGC Financial Services, LLC | 0.00% | No change | 300 | $612 |
| Bank of America Corp. | 0.00% | Reduce -0.3% | 240 | $490 |
| CIBC Private Wealth Group LLC | 0.00% | New | 222 | $433 |
| Osaic Holdings, Inc. | 0.00% | New | 120 | $245 |
| Atwood & Palmer Inc. | 0.00% | No change | 20 | $41 |
"% of holder's portfolio" is TRINITY BIOTECH INVT LTD's weight in each manager's 13F, not the share of Trinity Biotech Invt Ltd. the manager owns.